推薦產品
化驗
99%
形狀
rod
製造商／商標名
Goodfellow 552-484-53
電阻係數
126 μΩ-cm, 20°C
長度 × 直徑
100 mm × 12.5 mm
bp
3273 °C (lit.)
mp
1313 °C (lit.)
密度
7.886 g/mL at 25 °C (lit.)
SMILES 字串
[Gd]
InChI
1S/Gd
InChI 密鑰
UIWYJDYFSGRHKR-UHFFFAOYSA-N
尋找類似的產品？ 前往 產品比較指南
一般說明
For updated SDS information please visit www.goodfellow.com.
法律資訊
Product of Goodfellow
訊號詞
Warning
危險聲明
危險分類
Water-react 3
儲存類別代碼
4.3 - Hazardous materials which set free flammable gases upon contact with water
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Yongjun Liu et al.
Biomaterials, 33(21), 5363-5375 (2012-04-24)
Theranostic magnetic resonance imaging (MRI) is now receiving a growing interest in imaging-guided drug delivery, monitoring the treatment and personalized administration etc. Theranostic agents are essential for the usage of theranostic MRI. Among different kinds of theranostic agents, gadolinium loaded
Andrew J Swift et al.
JACC. Cardiovascular imaging, 7(12), 1209-1217 (2014-12-17)
The goal of this study was to determine the prognostic value of late gadolinium enhancement (LGE) cardiac magnetic resonance (CMR) features in patients with pulmonary hypertension. The prognostic significance of LGE in the clinical assessment of patients with pulmonary hypertension
Brigit den Adel et al.
Atherosclerosis, 225(2), 274-280 (2012-08-14)
MRI using targeted contrast agents (CA) has emerged as a promising technique to study atherothrombotic disease in vivo. Particularly, the use of targeted Gd and lipid-based nanoparticles has enabled detailed in vivo imaging of various molecular markers of atherosclerotic plaque
Kanae Kawai Miyake et al.
AJR. American journal of roentgenology, 203(2), 272-279 (2014-07-24)
The purpose of this study was to assess the diagnostic value of (18)F-FDG PET/CT and MRI in predicting the clinicopathologic subtypes of breast cancer. The cases of 89 patients with mass-type invasive breast cancer who underwent FDG PET/CT and MRI
Anders Bruun Mathiasen et al.
European heart journal, 36(27), 1744-1753 (2015-05-01)
Regenerative treatment with mesenchymal stromal cells (MSCs) has been promising in patients with ischaemic heart failure but needs confirmation in larger randomized trials. We aimed to study effects of intra-myocardial autologous bone marrow-derived MSC treatment in patients with severe ischaemic
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務